Alterity Therapeutics Share Price and Company Fundamentals

0.000 (0.000%)
52 week
0.013 - 0.034

Last traded: Yesterday at 6:10 AM

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Primary activitiesThe Company's business is the development of therapeutic drugs for age-related diseases.
Industry / SectorBiotechnology / Healthcare
Full time employees11
Mailing address460 Bourke Street Level 3 Melbourne VIC 3000 Australia
Phone / Fax61 3 9349 4906 / 61 3 9348 0377


More: Alterity Therapeutics Dividend history, yield and payout ratio

Dividend yield


Dividend amount


Payout ratio


Alterity Therapeutics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ATH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

ATH's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Alterity Therapeutics.

NameTitleAgeTotal Pay
Mr. Geoffrey Paul Kempler B.Sc, B.Sc.Co-Founder & Non-Exec. Chairman661.38M
Dr. David A. Stamler M.D.Chief Exec. Officer60606.06k
Ms. Kathryn J. E. AndrewsChief Financial Officer54347.93k
Dr. Rudolph Emile Tanzi Ph.D.Chief Scientific Advisor and Member of R&D Advisory Board62
Dr. Steven D. TargumChief Medical Advisor
Dr. Robert ChernyHead of Research
Mr. Phillip Allen Hains BBus(Acc), CA, MBACompany Sec.62

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Alterity Therapeutics is and its enterprise value is .

The ATH's stocks Beta value is 1.05 making it 5% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Alterity Therapeutics (ATH)

Alterity Therapeutics (ASX:ATH) Frequently Asked Questions

1. What is Alterity Therapeutics's Stock Symbol?

Alterity Therapeutics trades on ASX under the ticker symbol "ATH".

2. What is Alterity Therapeutics's stock price today?

One share of ATH stock can currently be purchased for approximately $0.016.

3. How can I contact Alterity Therapeutics?

Alterity Therapeutics's mailing address is 460 Bourke Street Level 3 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 9349 4906.

4. What is Alterity Therapeutics's official website?

The official website of Alterity Therapeutics is

5. Which share registry manages Alterity Therapeutics's stock?

Alterity Therapeutics's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.